Back
Novo Nordisk A/S Stock Predictions
Buy
74
NONOF
Novo Nordisk A/S
Last Price:
132.41
Seasonality Move:
3.75%
7 Day Trial
ALL ACCESS PASS
$
7
Novo Nordisk A/S Stock Forecast
- Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 26.8% based on the past 15 years of stock performance.
- Novo Nordisk A/S has risen higher in 12 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Novo Nordisk A/S Stock Undervalued?
The current Novo Nordisk A/S [NONOF] share price is $132.41. The Score for NONOF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal. - NONOF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk A/S Stock Go Up Next Year?
- Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 26.8% based on the past 15 years of stock performance.
Novo Nordisk A/S Stock Rating
Buy
74
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S overpriced?
- Novo Nordisk A/S has risen higher in 12 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Novo Nordisk A/S Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
140.32
52-Week Low:
74.70
Prediction Charts
Market Cap:
592.39B
Price in USD:
132.41
Volume:
4.54K
Beta:
0.51
Technical Analysis
SMA50:
127.65
SMA100:
120.82
SMA200:
108.43
52-Wk Change:
60.29%
Stock Predictions
-
Is Novo Nordisk A/S stock public?
Yes, Novo Nordisk A/S is a publicly traded company. -
What is the Novo Nordisk A/S stock quote today?
The Novo Nordisk A/S stock price is 132.41 USD today. -
How to buy Novo Nordisk A/S stock online?
You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 129.82 | 129.77 | 130.00 | 125.00 |
May-1 | 131.25 | 126.46 | 131.25 | 125.00 |
May-2 | 127.41 | 124.22 | 130.75 | 124.22 |
May-3 | 122.98 | 121.51 | 126.00 | 120.54 |
May-6 | 125.00 | 123.70 | 125.00 | 119.65 |
May-7 | 126.73 | 124.25 | 129.47 | 123.55 |
May-8 | 126.50 | 127.00 | 128.55 | 126.50 |
May-9 | 127.00 | 127.72 | 128.90 | 126.85 |
May-10 | 127.00 | 128.75 | 130.96 | 127.00 |
May-13 | 127.90 | 130.70 | 134.32 | 127.90 |
May-14 | 134.79 | 132.20 | 134.79 | 129.76 |
May-15 | 132.95 | 132.12 | 134.88 | 129.01 |
May-16 | 133.50 | 133.98 | 134.42 | 132.12 |
May-17 | 133.13 | 132.41 | 135.00 | 128.05 |
Novo Nordisk A/S Earnings
Novo Nordisk A/S Earnings Report: Per Share Novo Nordisk A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk A/S Forecast Revenue Growth
Novo Nordisk A/S Stock Analysis: Historical quarterly revenues per share for Novo Nordisk A/S and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.